Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry.
Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry.
复制标题
DOI:
10.1016/j.jacep.2022.03.001
复制
发表时间:
2022-06
影响因子:
7
通讯作者:
Holmes, David R.
中科院分区:
文献类型:
--
作者:
Alkhouli, Mohamad;Du, Chengan;Killu, Ammar;Simard, Trevor;Noseworthy, Peter A.;Friedman, Paul A.;Curtis, Jeptha P.;V. Freeman, James;Holmes, David R.
Data on the impact of residual peri-device leak following left atrial appendage occlusion [LAAO] are limited. to explore the association of peri-device leak with adverse clinical events. We queried the NCDR-LAAO Registry to identify patients undergoing LAAO between January-1st, 2016, and December-31st, 2019. Patients were classified according to leak size on 45+/−14 days echocardiography: (0mm, no leak; >0–5mm, small leak; >5mm, large leak). A total of 51,333 patients were included, of whom 37,696 (73.4%) had no leak, 13,258 (25.8%) had small leaks, and 379 (0.7%) had large leaks. The proportion of patients on warfarin at 45-day was higher in the large vs. small or no leak cohort (44.9% vs. 34.4% and 32.4%, respectively, p<0.001). At 6- and 12-month, anticoagulant utilization decreased but remained more frequent in patients with large leaks. Thromboembolic events were uncommon in all groups. However, compared with patients with no leak, those with small leaks had slightly higher odds of stroke/TIA/systemic embolization (adjusted hazard ratio [aHR] 1.152, 95%CI 1.025–1.294), major bleeding (HR 1.11, 95%CI 1.029–1.120), and any major adverse events (HR 1.102, 95%CI 1.048–1.160). There were no significant differences in adverse events between patients with large leaks and patients with small or no leaks. Small (0–5mm) leaks after LAAO were associated with modestly higher incidences of thromboembolic and bleeding events; large leaks (>5mm) were not associated with adverse events although higher proportions of these patients were maintained on anticoagulation. Newer devices with improved seal might mitigate the events associated with residual leaks. We queried the NCDR LAAO Registry to compare post-LAAO clinical outcomes stratified by the size of residual leak at 45-day TEE. Peri-device leak was absent in 37,696 (73.4%), small in 13,258 (25.8%), and large in 379 (0.7%). Compared with no leak, patients with small leaks had slightly higher odds of stroke/transient ischemic attacks/systemic embolization (aHR 1.152, 95%CI 1.025–1.294), major bleeding (HR 1.11, 95%CI 1.029–1.120), and any major adverse events (HR 1.102, 95%CI 1.048–1.160). Large leaks were not associated with higher adverse events although a higher proportion of those patients were maintained on anticoagulation at 45-day, 6-month, and 1-year.
登录
查看更多内容
影响因子:
11.3
作者:
Korsholm, Kasper;Berti, Sergio;Nielsen-Kudsk, Jens Erik
通讯作者:
Nielsen-Kudsk, Jens Erik
影响因子:
24
作者:
Viles-Gonzalez, Juan F.;Kar, Saibal;Reddy, Vivek Y.
通讯作者:
Reddy, Vivek Y.
影响因子:
8.9
作者:
Alkhouli M;Holmes DR
通讯作者:
Holmes DR
影响因子:
24
作者:
Darden, Douglas;Duong, Thao;Hsu, Jonathan C.
通讯作者:
Hsu, Jonathan C.
影响因子:
11.3
作者:
Korsholm, Kasper;Jensen, Jesper Moller;Nielsen-Kudsk, Jens Erik
通讯作者:
Nielsen-Kudsk, Jens Erik